References
1. Fried R, Merrell WC. The Arginine Solution. New York, NY. Warner Books, 1999.
2. Coffee, C J: Metabolism. Madison, Ct: Fence Creek Publishing, 1998.pp388-389
3. Catt KJ: Molecular Mechanisms of Hormone Action. In Endocrinology and Metabolism, 3rd ed. Edited by Felig P,
Baxter JD, Frohman LA. New York, NY: McGraw-Hill, 1995, pp 138-139
4. Gerhard M, et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels
of humans. Hypertension 1996 Apr;27(4):849-53
5. Toprakci M, et al. Age-associated changes in nitric oxide metabolites, nitrite and nitrate. Int J Clin Lab Res
2000;30(2):83-5
6. Sakuma I, et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad
Sci USA 1988 Nov;85(22):8664-7
7.Vallance P, Moncada S. Nitric Oxide—from mediator to medicines. J R Coll Physicians Lond 1994 May-Jun;28
(3): 209-219
8. Kam PC, Govender G. Nitric oxide: basic science and clinical applications. Anaesthesia 1994 Jun;49(6): 515-21
9. Sinha G. Viagra: ups and downs. Popular Science 2000 July: page 35
10. Boger RH, Bode-Boger SM, Kienke S, et al. Dietary L-arginine decreases myointimal cell proliferation and
vascular monocyte accumulation in cholesterol-fed rabbits.Atherosclerosis 1998 Jan;136(1) 67-77
11. Cheng JW, Balwin SN. L-Arginine in the management of cardiovascular diseases. Ann Pharmacother 2001
Jun;35(6):755-64
12. Tentolouris C, Tousoulis D, et al. L-Arginine in coronary atherosclerosis. Int J Cardiol 2000 Sep 15;75(2-
3):123-8
13. Wang B, Ho HV, et al. Regression of atherosclerosis. Circulation 1999;99(9):1236-41
14. Boger RH, Bode-Boger SM, et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol
fed rabbits: comparison with lovastatin. Circulation 1997; 96(4):1282-90
15. Schuschke DA, Miller FN, Lominadze DG, Feldhoff RC. L-arginine restores cholesterol-attenuated micro
vascular responses in the rat cremaster. Int J Micricirc Clin Exp 1994 Jul-Aug;14(4): 204-11
16. Orlandi A, Marcellini M Spagnoli LG. Aging influences development and progression of earl aortic
atherosclerosis lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasac Biol 2000 Apr;20
17. Chong PH, Bachenheimer BS. Current, New and future treatments in dyslipidemia and atherosclerosis. Drugs
2000 Jul;60(1):55-93
18. Phivthong-ngam L, Bode-Boger SM, Boger RH, et al. Dietary L-arginine normalizes endothelial induced
vascular contractions in cholesterol-fed rabbits. J Cardiovasc Pharmacol 1998 Aug;32(2): 300-7
19. Maxwell AJ, Anderson B Zapien MP, Cooke JP. Endothelial dysfunction in hypercholesterolemia is reversed
by: nutritional product designed to enhance nitric oxide activity. Cardiovasc Drugs Ther 2000 Jun;14(3):309-16
20. Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves endothelial-dependent dilation in
hypercholesterolemic young adults. J Clin Invest 1996 April; 97(8): 1989-94
21. Cooke JP, Dzau J, Creager A. Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine. Basic
Res Cardiol 1991; 86 Suppl 2: 173-81
22. Fraser GE. Diet and coronary heart disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J
Clin Nutr 1994 May;59(5 Suppl) 1117s-1142sand atherosclerosis. Drugs 2000 Jul;60(1):55-93
23. Quyyumi AA. Does acute improvement of endothelial dysfunction in coronary arterydisease improve
myocardial ischemia? J Am Coll Cardiol 1998 Oct;32(4):904-11
24. Lerman A, Burnett JC Jr, Higano ST, et al. Long-term L-arginine supplementation improves small vessel
coronary endothelial function in humans. Circulation 1998 Jun 2;97(21):1648-9
25. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise
capacity in patients with stable angina pectoris. Am J Cardiol 1997 Aug 1; 80(3):331-3
26. Desrois M, Sciaky M, Lan C, et al. L-arginine during long-term ischemia: effects on cardiac function, energetic
metabolism and endothelial damage. J Heart Lung Transplant 2000 April; 19(4): 367-76
27. Quyyumi AA, Dakak N, Dodati JG, et al. Effect of L-arginine on human coronary endothelium-dependent and
physiologic vasodilation, J AM Coll Cardiol 1997 Nov 1; 30(5):1220-7
28. Egashira K, et al. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in
patients with angina pectoris and normal coronary arteriograms. Circulation 1996;94(2):130-4
29. Tentoluris C, et al. L-arginine in coronary atherosclerosis. Int J Cardiol 2000 Sep15;75(2-3):123-8
30. Tretjakovs P, Kalnins U, Dabina I, et al. Plasma HDL-cholesterol has an effect on nitric oxide production and
arachidonic production in the platelet membranes of coronary artery disease patients without LDLhypercholesterolemia.
Med Sci Monitor 2000 May- Jun;6(3):507-11
31. Bode-Boger SM, Boger RH, Galland A, Tsikas D Frolich JC. L-arginine induced vasodilatation in healthy
humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 1998 Nov; 46(5): 489-97
32. Khedara A, Kawai Y Kayashita J Kato N. Feeding rats the nitric oxide synthase inhibitor, L-N(omega)
nitroarginine, elevates serum triglycerides and cholesterol and lowers hepatic fatty acid oxidation. J Nutr 1996
Oct;126(10):2563-7
33. Boger RH, Bode-Boger SM, Theil W, et al. Restoring vascular nitric oxide formation by L-arginine improves
symptoms of intermittent claudication in patients with Peripheral arterial occlusive disease. J Am Col Cardiol
1998 Nov;32(5):1336-44
34. Maxwell AJ, Anderson BE Cooke JP. Nutritional therapy for peripheral artery disease. Vasc Med 2000;5(1):11-19
35. Hiatt WR. New treatment options in intermittent claudication: the US experience. Int J Clin Pract Suppl 2001
Apr;(119):20-27
36. Creager MA. Medical management of peripheral artery disease. Cardiol Rev 2001 Jul-Aug;9(4):238-45
37. Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster HE. A randomized double-blind study of oral Larginine
for treatment of interstitial cystitis. J Urol 1999 Feb; 161(2):558-65
38. Cartledge JJ, Davies AM, Eardley I. A randomized double-blind placebo-controlled crossover trial of the
efficacy of L-arginine in the treatment of interstitial cystitis. BJU Int 2000 Mar; 85(4):421-6
39. Sisic D, Francishetti A, Frolich ED. Prolonged L-arginine on cardiovascular mass and myocardial
hemodynamics and collagen in aged spontaneously hypertensive and normal rats. Hypertension 1999 Jan;33(1
Pt 2):451-5
40. Higashi Y, et al. Effects of L-arginine infusion on renal hemodynamics in patients with mild hypertension.
Hypertension1995;25(4):898-902
41. Hishikawa K, et al. Role of L-arginine-nitric oxide pathway in hypertension. J Hypertens 1993 Jun; 11(6):639-45
42. Dominiczak AF, Bohr DF. Nitric oxide and its’ putative role in hypertension. Hypertension 1995;25(6):1202-11
43. Nakaki T, et al. L-arginine induced hypotension. Lancet 1990Oct 20; 336(8721):1016-7
44. Braga M, Gianotti L Raedelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery:
results of a randomized double-blind phase 3 trial. Arch Surg 1999 Apr;134(4):428-33
45. Ghigo E, Aimaretti G, Cornelli G, et al. Diagnosis of GH deficiency in adults. Growth Hormone IGF Res 1998
Feb;8 Suppl A:55-8
46. Wideman L Weltman JY, Patrie JY, et al. Synergy of L-arginine and GHRP-2 stimulation of growth hormone in
men and women: modulation by exercise. Am J Physiol Regul Integr Comp Physiol 2000 Oct;279(4):R1467-77
47. Gianotti L, Macario M, Lanfranco F, et al. Arginine counteracts the inhibitory effect of recombinant human
insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in
humans. J Clin Endocrinol Metab 2000 Oct;85(10):3604-8
48. Mauras N, Walton P, Nicar M, et al. Growth hormone stimulation testing in both short and normal statured
children. Pediatr Res 2000 Nov;48(5):579-80
49. Ghigo E, Arvat E, Gianotti L, et al. Hypothalamic growth hormone-insulin-like growth facto-1 axis across the
human life span. J Pediatr Endocrinol Metab 2000;13 Suppl 6:1493-502
50. Korbonits M, Kaltsas G, Perry LA, et al. The growth hormone secretagogue hexarelin stimulates the
hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 1999 Jul;84(7):2489-95
51. Wallace AW, Ratcliffe MB, Galindez D, Kong JS. L-arginine infusion dilates coronary vasculature in patients
undergoing coronary bypass surgery Aenesthesiology 1999 Jun;90(6):1577-8
52. Chen J, Wollman Y, Chernichovsky T, et al. Effect of high dose nitric oxide donor L-arginine in men with
organic erectile dysfunction. BJU Int 1999 Feb;83(3):269-73
53. Kobayashi N, Nakamura M, Hiramori K. Effects of infusion of L-arginine on exercise-induced myocardial
ischemic changes and capacity to exercise of patients with stable angina pectoris. Coron Artery Dis 1999
Jul;10(5):321-6
54. Bednarz B, Wolk R, Chamiec T, et al. Effects of oral L-arginine supplementation on exercised induced QT
dispersion and exercise tolerance in stable angina pectoris.Int J Cardiol 2000 Sep 15; 75(2-3): 205-10
55. De Nicola L, Bellizzi V, Minutolo R, et al. Randomized, double-blind, placebo controlled study of arginine
supplementation in chronic renal failure. Kidney Int 1999 Aug;56(2):674-84
56. Watanabe G, Tomiyama H, Doba N. Effects of oral L-arginine on renal function in patients with heart failure. J
Hypertens 2000 Feb;18(2):229-34
57. Kelly BS, Alexander JW Dreyer D, et al. Oral arginine improves blood pressure in renal transplant and
hemodialysis patients. J Parenter Enteral Nutr 2001 Jul-Aug; 25(4): 194-202
58. Efron DT, Barbul A. Arginine and nutrition in renal disease. J Ren Nutr 1999 Jul;9(3):142-4
59. Reckelhoff JF, et al. Long-term dietary supplementation with L-arginine prevents age related reduction in renal
function. Am J Physiol 1997 Jun; 272(6 Pt 2):1768-74
60.Reyes AA, Purkerson ML, Karl L, Klahr S. Dietary supplementation with L-arginine ameliorates the
progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992 Aug; 20(2):454-5
61. Bradley SJ, Kingwell BA, McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not
blood flow during dynamic exercise in humans. Diabetes 1999 Sep; 48(9):1815-21
62. De Gouw HW, Verbruggen MB, Twiss IM, Sterk PJ. Effect of oral L-arginine on airway hyper-responsiveness
to histamine in asthma. Thorax 1999 Nov;54(11):1033-5
63. De Gouw HW, Marshall-Partridge SJ, et al. Role of nitric oxide in the airway response to exercise in healthy
and asthmatic subjects. J Appl Physiol 2001 Feb;90(2):586-92
64. Boer J, et al. Role of L-arginine deficiency of nitric oxide and airway hyperreactivity after allergen-induced
early asthmatic reaction in guinea-pigs. Br J Pharmacol 1999 Nov;128(5):1114-20
65. Blease K, Kunkel SL, Hogaboam CM. Acute inhibition of nitric oxide exacerbates airway hyperresponsiveness,
eosinophilia and C-C chemokine generation in a murinemodel of fungal asthma. Inflamm Res 2000 Jun;
49(6):297-304
66. Du J, Cui D, Tian D. [ The role of nitric oxide in the pathogenesis of asthma.] [ Full text in Chinese] Zhonghua
Jie He He Hu Xi Za Zhi 1997 Jun;20(3):153-6
67. Gionotti L, Braga M, Fortis C, et al. A prospective, randomized clinical trial on perioperative feeding with an
arginine-, omega-3 fatty acid-, and RNA enriched enteral diet: effect on host response and nutritional status. J
Parenter Enteral Nutr1999 Nov- Dec;23(6):314-20
68. Efron D, Barbul A. Role of arginine in immunonutrition. J Gastroentol 2000;35 Suppl 12:20-3
69.Lewis B, Langkamp-Henken B. Arginine enhances in vivo immune responses in young, adult and aged mice.
J Nutri 2000;130(7):1827-30
70. Mannick JB, et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus
reactivation. Cell 1994 Dec 30;79(7):1137-46
71.Ochoa JB, et al. Effects of L-arginine on the proliferation of T-lymphocyte subpopulations. J Parenter
Enteral Nutr 2001 Jan-Feb;25(1):23-9
72. di Luigi L, Guidetti L, Pigozzi F, et al. Acute amino acid supplementation enhances pituitary responsiveness in
athletes. Med Sci Sports Exerc 1999 Dec;31(12):1748-54
73. Lawecki J et al. Serum insulin, pancreatic glucagons and growth hormone levels in response to intravenous
infusion of L-arginine in patients with recently detected juvenile diabetes. Pol Med Sci Hist Bull 1976 Apr-
Jun;15(2):177-82
74. Valcenti S, et al Biphasic effect of nitric oxide on testosterone and cyclic GMP productionby purified rat Leydig
cells cultured in vivo. Int J Androl 1999 Oct; 22(5):336-41
75. Stevens BR, Godfrey MD, Kaminski TW, Braith RW. High intensity dynamic human muscle performance
enhanced by a metabolic intervention. Med Sci Sports Exerc 2000 Dec;32(12):2102-8
76. Piatti PM, Monti LD, Valsecchi G, et al. Long term oral L-arginine administration improves peripheral and
hepatic insulin sensitivity in type 2 diabetes. Diabetes Care 2001 MAY;24(5):875-80
77. Giugliana D, et al. Vascular effects of acute hyperglycemia are reversed by L-arginine. Circulation 1997;
95(7):1783-90
78. Mohan IK, Cas UN. Effects of L-arginine-nitric oxide system on chemical induced diabetes mellitus. Free
Radic Biol Med 1998 Nov 1;25(7):757-65
79. Mendez JD, Balderas F. Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in Diabetic
rats. Biochemie 2001 May;83(5):453-8
80. Kaposzta Z, et al. L-arginine and S-nitroglutathione reduce embolization in Humans. Circulation
2001;103(19):2371-75
81. Bode-Boger SM, Boger RH, et al. Differential inhibition of human platelet aggregation and thromboxane A 2
formation by L-arginine in vivo and in vitro. Arch Pharmacol 1998; 357:143-150
82. Wolf A, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic
humans. J Am Coll Cardiol 1997 Mar 1; 29(3):479
83. Le Yorneau T, Van Belle E, Corseaux D, et al . Role of nitric oxide in re-stenosis after experimental balloon
angioplasty in the hypercholesterolemic rabbit. J Am CollCardiol 1999 Mar;33(3):876-82
84. Janero DR, Ewing JF. Nitric Oxide and Postangioplasty re-stenosis: Pathologicalcorrelates and therapeutic
potential. Free Radic Biol Med 2000 Dec 15;29(12):1199-221/login?_sid=pA9K2IlHelvFq5Sm39sxDVozX3 gt;
85. Severin P, et al. Local intramural delivery of l-arginine enhances nitric oxide generation and inhibits lesion
formation after balloon angioplasty. Circulation 1997;95(7):1863-9
86. Thomas S, Ramachandran A, Patra S, et al. Nitric oxide protects the intestine from the damage induced by
laparotomy and gut manipulation. J Surg Res 2001 Jul;99(1):25-32
87.Sahin AS, Atalik KE, Gunel E, Dogan N. Nonadrenergic, noncholinergic responses of the human colon
smooth muscle and the role of K+channels in these responses.. Methods Find Exp Clin Pharmacol 2001 Jan-
Feb;23(1):13-7
88. Fini M, et al. Effect of l-lysine and L-arginine on primary osteoblast cultures from normal and osteopenic rats
Biomed Pharmacother 2001 May;55(4):213-21
89. Aikawa K, Yokota T, et al. Endogenous nitric oxide-mediated relaxation and nitrinergic innervation in the
rabbit prostate: the change with aging. Prostate 2001 Jun 15;48(1):40-6
90. Suematsu Y, Ohtsuka T, et al. L-Arginine given after ischemic preconditioning can enhance cardioprotection in
isolated rat hearts. Eur J Cardiothorac Surg 2001, Jun;19(6):873-9
91. Koglin J. Pathogenetic mechanisms of cardiac allograft vasculopathy-impact of nitric oxide. Z Kardiol 2000;89
Suppl 9:IX/24-7
92. Kown MH, Van Der Steenhoven T, Uemura S, et al. L-Arginine polymer mediated inhibition of graft coronary
artery disease after cardiac transplantation. Transplantation 2001 June 15;71(11):1542-8
93. Freedman RR, Girgis R, Mayers MD. Acute effect if nitric oxide on Raynaud’s phenomenon in scleroderma.
Lancet 1999 Aug 28:354;739
94. Morric CR, Kuypers FA, et al. Patterns of arginine and nitric oxide in patients with sickle cell disease with
vaso-occlusive crisis and acute chest syndrome. J Ped Hemat/Onc 2000 Nov-Dec;22(6):515-20
95. Kumar CA, Das UN. Lipid peroxides, antioxidants and nitric oxide in patients with pre-eclampsia and essential
hypertension. Med Sci Monitor 2000 Sep-Oct;6(5):901-7
96. Nagaya N, Uematsu M, et al. Short term oral administration of l-arginine improves hemodynamics and exercise
capacity in patients with precapillary pulmonary hypertension. Am J Resp Crit Care Med 2001
April;163(4):887-91
97. Barbul A, et al. Arginine enhances wound healing and lymphocyte immune responsesin humans. Surgery 1990
Aug;108(2):331-6; discussion 336-7
98. Kirk SJ, et al Arginine stimulates wound healing and immune function in elderly humans. Surgery 1993
Aug;114(2):155-9; discussion 160
99. De-Souza DA, Greene LJ. Pharmacological nutrition after burn injury. J of Nutri 1998 May;128(5):797-803
100. Blum A, Cannon RO, Costello R, et al. Endocrine and lipid effects of oral L-arginine treatment in healthy
postmenopausal women. J Lab Clin Med 2000 Mar;135(3):231-7
101.Ohta Y, Nishida K., Protective effect of l-arginine against stress-induced gastric mucosal lesions in rats and
its relation to nitric acid-mediated inhibition of neutrophil infiltration. Pharmacal Res 2001 Jun;43(6):535-41
102. Khattab MM, Gad MZ, Abdallah D. Protective role of nitric oxide in indomethacin- induced gastric ulceration
by a mechanism independent of gastric acid secretion. Pharmacol Res 2001 May;43(5):463-7
103. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991
Nov;81(5):695-700
104. Bode-Boger SM, Boger RH,et al. L-arginine induces nitric oxide-dependent vasodilation in patients with critical
limb ischemia. A randomized, controlled study. Circulation 1996 Jan 1; 93(1):85-90
105. Vallet B. Microthrombosis in sepsis. Minerva Anestesiol 2001 Apr;67(4):298-301.
106. Hambrecht R, et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise
training and oral L-arginine supplementation. J Am Coll Cardiol 2000 Mar 1; 35(3):706-13
107. Heys SD, et al. Dietary supplementation with L-arginine: Modulation of tumor infiltrating lymphocytes in
patients with colo-rectal cancer. Br J Surg 1997 Feb;84(2):238-41
108. Brittenden J, et al. Dietary supplementation with L-arginine in patients with breast cancer(> 4cm.) receiving
multi-modality treatment: report of a feasibility study. Br J Cancer 1994 May;69(5):918-21
109. McCarty MF. Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer’s
disease by suppressing synthesis of acute-phase cytokines. Med Hypotheses 1999 Nov;53(3):369-74
110. Tarkowski E, et al. Intrathecal release of nitric oxide in Alzheimer’s disease and vascular dementia. Dement
Geriatr Cogn Disord 2000 Nov- Dec;11(6):322-6
111. de la Torre JC, Stefano GB. Evidence that Alzheimer’s disease is a microvascular disorder: the role of
constitutive nitric oxide. Brain Res Brain Res Rev 2000 Dec;34(3):119-36
112. Kuiper MA, et al. Decrease cerebrospinal fluid nitrate levels in Parkinson’s disease, Alzheimer’s disease and
multiple system atrophy patients. J Neurol Sci 1994 Jan; 121(1):46-9
113. Pautler EL. The possible role and treatment of deficient microcirculation regulation in age-associated memory
impairment. Med Hypotheses 1994 Jun;42(6):363-6
114. Pandhi P, Balakrishnan S. Cognitive dysfunction induced by phenytoin and valproate in rats: effect of nitric
oxide. Indian J Physiol Pharmacol 1999 Jul; 43(3):378-82
115. Pendergast MA, et al. Nitric oxide synthase inhibition impairs delayed recall in mature monkeys. Pharmacol
Biochem Behav 1997 Jan;56(1):81-7
116. Fideieff HL,et al. Reproducibility and safety of the arginine test in normal adults.Medicina (B Aires) 1999;
59(3):249-53
117. Fagan JM, et al. L-arginine reduces right heart hypertrophy in hypoxia-induced pulmonary hypertension.
Biochem Biophys Res Commun 1999 Jan 8; 254(1):100-3
118. Nitric oxide and pulmonary hypertension. Coron Artery Dis 1999 Jul; 10(5):287-94
|